Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.




This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Ramin Ebrahimi, MD

Director of Cardiac Catheterization Lab
Wadsworth VA Medical Center
Member of the Healthcare Council

Ramin Ebrahimi, MD, is an Associate Clinical Professor at the University of California, Los Angeles. He is also the Director of the Cardiac Catheterization Laboratory and Assistant Director of Nuclear Cardiology at the Wadsworth VA Medical Center. Dr. Ebrahimi’s clinical and research interests focus on interventional cardiology, acute coronary syndromes, invasive and interventional devices, obesity, metabolic syndromes, dyslipidemia, heart failure, and peripheral arterial disease. He is the Principal Investigator on various clinical trials and has made several contributions to the ACS and interventional cardiology literature. Dr. Ebrahimi is a national speaker in the fields of acute coronary syndromes, peripheral arterial disease, and metabolic syndromes. He is on the editorial board of the Journal of Cardiovascular Pharmacology and Therapeutics and a reviewer for the American Journal of Cardiology. Dr. Ebrahimi is also an invited faculty to the TCT meetings. (This is me - Update Profile)


Employment History
1999 - present Associate Clinical Professor
University of California, Los Angeles
1999 - present Director of Cardiac Catheterization Lab
Wadsworth VA Medical Center
1995 - 1999 Assistant Clinical Professor
University of California Irvine
1994 - 1995 Instructor in Medicine
Boston University

GLG Study Groups with Ramin Ebrahimi, MD(?)

View All Study Groups with Ramin Ebrahimi, MD

GLG NewsSM Analyses by Ramin Ebrahimi, MD(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Risk Versus Benefit | 11-23-2007
Analysis of: Study Shows Weight-Loss Drug Rimonabant is Associated with Severe Adverse Psychiatric Events | pharmalive.com
Author: Ramin Ebrahimi, MD, Director of Cardiac Catheterization Lab, Wadsworth VA Medical Center

The pooled analysis of Rimonabant trials point to a significant increase in psychiatric disorders. These studies also point to significant improvements in markers of cardiovascular risk. Risks versus benefits must be considered before the final decision is made on this class of medications.

Good device but not much improvement. | 08-31-2007
Analysis of: St. Jude Medical Announces Japanese Approval Of The Angio-Seal STS Plus Vascular Closure Device | www.medicalnewstoday.com
Author: Ramin Ebrahimi, MD, Director of Cardiac Catheterization Lab, Wadsworth VA Medical Center

The repositioning of the hole, also present with the VIP version is a mild improvement to decrease sheath manipulation. Otherwise the device has not changed much in the past few years. While a very good device in general, its primary limitaions listed below still remain. 1. not allowing re-access...

GLG InstituteSM Seminars with Ramin Ebrahimi, MD(?)

 
Ramin Ebrahimi, MD has not participated in any GLGi Seminars.
View all GLG InstituteSM Seminars in Healthcare

Request a project with Ramin Ebrahimi, MD









Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics